G. Walsh

2.3k total citations
39 papers, 1.5k citations indexed

About

G. Walsh is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, G. Walsh has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Cancer Research and 10 papers in Pathology and Forensic Medicine. Recurrent topics in G. Walsh's work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (18 papers) and Breast Lesions and Carcinomas (8 papers). G. Walsh is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (18 papers) and Breast Lesions and Carcinomas (8 papers). G. Walsh collaborates with scholars based in United Kingdom, Australia and Switzerland. G. Walsh's co-authors include Ian E. Smith, S. Ashley, S. Ebbs, Stephen Johnston, J A McKinna, Christopher Flower, John M. Shneerson, Ravi Mahadeva, Peter Ellis and N Sacks and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

G. Walsh

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Walsh United Kingdom 20 827 783 379 289 229 39 1.5k
Pinuccia Valagussa Italy 10 1.2k 1.5× 1.0k 1.3× 439 1.2× 256 0.9× 208 0.9× 11 1.8k
Manuel Ramos Spain 16 846 1.0× 688 0.9× 313 0.8× 288 1.0× 109 0.5× 65 1.3k
Holm Eggemann Germany 22 694 0.8× 651 0.8× 214 0.6× 238 0.8× 382 1.7× 76 1.6k
R. Largillier France 14 940 1.1× 527 0.7× 231 0.6× 334 1.2× 90 0.4× 47 1.5k
Carl M. Sutherland United States 19 815 1.0× 499 0.6× 301 0.8× 249 0.9× 150 0.7× 42 1.4k
L. G. Dressler United States 17 595 0.7× 541 0.7× 223 0.6× 175 0.6× 134 0.6× 32 1.2k
Lorie L. Hughes United States 15 1.1k 1.3× 1.5k 2.0× 804 2.1× 344 1.2× 203 0.9× 22 2.2k
Naveen Faridi Pakistan 24 570 0.7× 345 0.4× 311 0.8× 265 0.9× 92 0.4× 85 1.4k
Caroline Seynaeve Netherlands 16 570 0.7× 378 0.5× 334 0.9× 353 1.2× 190 0.8× 24 1.1k
G. N. Hortobagyi United States 21 1.4k 1.7× 617 0.8× 255 0.7× 465 1.6× 244 1.1× 109 2.1k

Countries citing papers authored by G. Walsh

Since Specialization
Citations

This map shows the geographic impact of G. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Walsh more than expected).

Fields of papers citing papers by G. Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Walsh. The network helps show where G. Walsh may publish in the future.

Co-authorship network of co-authors of G. Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of G. Walsh. A scholar is included among the top collaborators of G. Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Walsh. G. Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stogiannos, Nikolaos, Georgia Pavlopoulou, Chris Papadopoulos, et al.. (2023). Strategies to improve the magnetic resonance imaging experience for autistic individuals: a cross-sectional study exploring parents and carers’ experiences. BMC Health Services Research. 23(1). 1375–1375. 10 indexed citations
2.
Walsh, G., Tom Meagher, & Christina Malamateniou. (2020). Evaluating the use of gradient echo imaging for the detection of cerebral microbleeds in acute stroke cases: A retrospective data analysis in a UK stroke unit. Radiography. 27(2). 561–567. 1 indexed citations
3.
Yeo, Belinda, et al.. (2015). Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab. The Breast. 24(6). 751–757. 31 indexed citations
4.
König, Kai, et al.. (2014). The relationship between BNP, NTproBNP and echocardiographic measurements of systemic blood flow in very preterm infants. Journal of Perinatology. 34(4). 296–300. 9 indexed citations
5.
O’Neill, Suzanne C., et al.. (2012). Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes. Annals of Oncology. 24(1). 133–138. 52 indexed citations
6.
Dolly, Saoirse, Amna Sheri, Marina Parton, et al.. (2010). Is Capecitabine Efficacious in Triple Negative Metastatic Breast Cancer?. Oncology. 79(5-6). 331–336. 8 indexed citations
7.
8.
Sirohi, Bhawna, Mónica Arnedos, Sanjay Popat, et al.. (2008). Platinum-based chemotherapy in triple-negative breast cancer. Annals of Oncology. 19(11). 1847–1852. 180 indexed citations
9.
Urruticoechea, Ander, Caroline Archer, L. Assersohn, et al.. (2005). Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer. British Journal of Cancer. 92(3). 475–479. 14 indexed citations
10.
Boer, Richard H. De, Tim Eisen, Peter Ellis, et al.. (2002). A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer. Annals of Oncology. 13(6). 889–894. 5 indexed citations
11.
Boer, Richard H. De, W H Allum, S. Ebbs, et al.. (2000). Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?. Annals of Oncology. 11(9). 1147–1154. 34 indexed citations
12.
Mahadeva, Ravi, G. Walsh, Christopher Flower, & John M. Shneerson. (2000). Clinical and radiological characteristics of lung disease in inflammatory bowel disease. European Respiratory Journal. 15(1). 41–48. 153 indexed citations
13.
Boer, Richard H. De, Andrea Saini, Stephen Johnston, et al.. (2000). Continuous infusional combination chemotherapy in inflammatory breast cancer: a phase II study. The Breast. 9(3). 149–155. 11 indexed citations
14.
Seymour, Michel, et al.. (1997). Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer. British Journal of Cancer. 76(3). 371–376. 15 indexed citations
15.
Walsh, G. & M. Williams. (1995). Congenital anomalies of the portal venous system-CT appearances with embryological considerations. Clinical Radiology. 50(3). 174–176. 19 indexed citations
16.
Jones, Anna, Ian E. Smith, Mary O’Brien, et al.. (1994). Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.. Journal of Clinical Oncology. 12(6). 1259–1265. 65 indexed citations
17.
18.
Price, P., G. Walsh, A McKinna, S. Ashley, & John Yarnold. (1988). Patterns of breast relapse after local excision ± radiotherapy for early stage breast cancer. Radiotherapy and Oncology. 13(1). 53–60. 17 indexed citations
19.
Palmer, B V, et al.. (1977). A survey of patients' reactions to intravenous Corynebacterium parvum therapy.. PubMed. 38. 529–33. 2 indexed citations
20.
McIntosh, Iain, et al.. (1977). Combination chemotherapy in metastatic breast cancer. BMJ. 2(6079). 122.5–122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pinuccia Valagussa Breakdown of academic impact, for papers by Manuel Ramos Breakdown of academic impact, for papers by Holm Eggemann Breakdown of academic impact, for papers by R. Largillier Breakdown of academic impact, for papers by Carl M. Sutherland Breakdown of academic impact, for papers by L. G. Dressler Breakdown of academic impact, for papers by Lorie L. Hughes Breakdown of academic impact, for papers by Naveen Faridi Breakdown of academic impact, for papers by Caroline Seynaeve Breakdown of academic impact, for papers by G. N. Hortobagyi
Rankless by CCL
2026